Search Results - Scott Nash
- Showing 1 - 4 results of 4
-
1
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps by Claus Bachert, Claus Bachert, Alexandra Hicks, Simon Gane, Anju T. Peters, Philippe Gevaert, Scott Nash, Julie E. Horowitz, Harry Sacks, Juby A. Jacob-Nara
Published in Frontiers in Immunology (2024-04-01)Get full text
Article -
2
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial by Wytske J Fokkens, Claus Bachert, Claire Hopkins, Osama Marglani, Amy Praestgaard, Scott Nash, Yamo Deniz, Paul J Rowe, Harry Sacks, Juby A Jacob‐Nara
Published in Clinical & Translational Immunology (2024-01-01)Get full text
Article -
3
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps by Philippe Gevaert, Stella E Lee, Russell A Settipane, Martin Wagenmann, Jérôme Msihid, Shahid Siddiqui, Scott Nash, Juby A Jacob‐Nara, Asif H Khan, Siddhesh Kamat, Chien‐Chia Chuang
Published in Clinical & Translational Immunology (2023-01-01)Get full text
Article -
4
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps by Shahid Siddiqui, Claus Bachert, Adam M. Chaker, Joseph K. Han, Peter W. Hellings, Anju T. Peters, Enrico Heffler, Siddhesh Kamat, Haixin Zhang, Scott Nash, Asif H. Khan, Lucia De Prado Gomez, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz
Published in ERJ Open Research (2022-11-01)Get full text
Article
